Genetics of Colon Cancer - Cormier, Nikcevich, Elliott Flashcards

1
Q

What is the epidemiology of colorectal cancer?

A
  • 2nd leading cause of cancer death in US
    • (11% of all cancer deaths)
    • ~ 143,000 new cases (2,200 in MN)
    • 51,000 deaths (800 in MN) yearly; worldwide more than 1 million cases
    • 620,000 deaths yearly
    • ~ 5% of the US population will develop CRC and ~ 50% will develop tumors
  • A significant disease in the western world (USA, Europe, Australia, NZ)
    • previously, much less so in Asia & Africa, but rates are increasing everywhere (especially China)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the racial epidemiology of colorectal cancer?

A
  • some differences by race within US:
    • African Americans have the highest incidence and present with more advanced disease
    • American Indians in Great Lakes & Minnesota have the highest rate of CRC
  • men in the USA develop CRC at higher rates than women and also have a higher mortality rates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the survival rate of colorectal cancer?

A
  • 30% present with metastatic disease (~11% 5 year survival)
  • overall 5 year survival rates for CRC = 45-50%
    • 50% of “cures” relapse and die from their cancer
    • survival rates drop significantly with advanced stages of the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the environmental risk factors that influence the development of colorectal cancer?

A
  • obesity is the greatest risk factor for colorectal cancer
  • sedentary lifestyle/lack of exercise
  • smoking
  • influence of dietary factors → poor diet
    • can act synergistically, and can interact with selected genetic changes in tumors or with host genetic factors
    • particular foods:
      • red meat, *w-6 FA, trans fats
      • processed meats
      • alcohol
      • low calcium & low folate
  • “Metabolic syndromes” → cardiovascular disease and type-2 diabetes that include: glucose intolerance, insulin resistance, dyslipidemia, obesity & hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What factors are protective or decrease the risk of colorectal cancer?

A
  • estrogen
  • chemopreventative agents
    • NSAIDS
    • 5-ASA
    • statins (?))
  • marine oils, w-3 FA (DHA, EPA), fruits, green leafy veggies, cruciferous
  • soy & phytoestrogens
  • fiber, folate, calcium, green tea, garlic, vitamins A,C,D,E
  • flavinoids, curcumin, resveratrol, caloric restriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the basic the genetics of colorectal cancer, both the inherited and sporadic forms?

A
  • hereditary syndromes (FAP, Lynch/HNPCC) (~5%) vs sporadic (~ 95%) CRC
  • at the molecular genetic level two types of CRC predominate:
    • 1) APC pathway that involves chromosomal instability (CIN)
    • 2) mismatch repair (MMR) gene pathway that involves microinstability (MIN)
    • both of these classes have hereditary syndromes and sporadic forms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the key role of the gatekeeper gene APC in both the inherited and sporadic forms of the disease?

A
  • APC is a classic tumor suppressor gene (Knudson’s two-hit hypothesis), thus expression of both copies must be lost in tumorigenesis
  • APC loss is rate-limiting in adenomagenesis based on two observations:
    • 1) APC mutations occur at similar rates in benign and malignant lesions
    • 2) APC mutations are seen in the earliest detectable lesions, some only a single crypt in size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the key role of the gatekeeper gene MLH1 in both the inherited and sporadic forms of the disease?

A
  • mismatch repair gene
    • mediates protein-protein interactions during mismatch recognition, strand discrimination, and strand removal
  • Defects in MLH1 are associated with the microsatellite instability (MSI) observed in HNPCC
    • hypermethylation and silencing of MLH1 - leading to MMR deficiency (primarily in sporadic MIN-associated CRC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the various methods for screening for colorectal cancer?

A
  • colonoscopy - gold standard, 100% accurate, 60% reduction in mortality
    • endoscopist skill greatly influences effectiveness (recent evidence)
  • CT colonography (CTC) virtual colonoscopy under development not as sensitive as endoscopy
  • flexible sigmoidscopy and barium enemas still have some utility but are less employed today and less accurate than colonoscopy
  • stool DNA - PCR analysis of shed tumor DNA such as APC, p53, RAS, BAT-26, mVIMENTIN >90% sensitivity & specificity
  • fecal occult blood - 50% sensitivity (25% adenomas), 98% specificity; 15% reduction in CRC mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the various methods for mutational analysis in colorectal cancer?

A
  • Sequencing (esp. NGS)
  • protein truncation tests
  • immunohistochemistry
  • Westerns
  • northerns
  • gene chips
  • PCR for microsatellite instability (MIN) (e.g., BAT-26)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most common form of metastases in Colorectal Cancer?

A
  • local site of CRC metastasis are the mesenteric lymph nodes
  • distant site is most often the liver, next lung, often present as numerous undetectable micrometastases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Based on molecular genetics, what are the features of APC/CIN type Colorectal cancer?

A
  • complete disruption of APC and/or its pathway (WNT/beta catenin)
  • chromosomal instability (CIN)
  • mostly left side
  • often loss of p53
  • increased RAS activity
  • hereditary syndrome: FAP (thousands of tumors)
  • ~ 85% of all CRC
  • poor prognosis (30% survival)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Based on molecular genetics, what are the features of MMR/MIN type Colorectal cancer?

A
  • complete loss of mismatch repair (MMR) (mostly MLH1 or MSH2)
  • microsatellite instability (MIN)
  • mostly right side
  • methylator phenotype common
  • hereditary syndrome: Lynch (a sub-type of HNPCC, 1 or several tumors)
  • ~ 15% of all CRC
  • better prognosis (90% survival)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is there a great need for better targeted therapies?

A
  • only 50% of individuals in the US > 50 years receive any of the recommended screening tests
    • among these those who receive screening the quality is variable
  • there are virtually no biomarkers that are useful in predicting response to treatment strategies
    • the best one at the present time is the presence of K-Ras mutations
  • current treatments for metastatic CRC extends life for months only
  • some new treatments offer limited improvement (e.g., VEGFR and EGFR Mabs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does APC resist cancer?

A
  • likely in multiple ways at different stages
    • regulation of b-catenin/Wnt pathway is well-known and probably its most important function
    • APC is also involved in cell adhesion, migration, cytoskeletal integrity and chromosomal fidelity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is predictive testing recommended for colorectal cancer?

A
  • 1st degree relative with known gene mutation
  • Pattern of cancers in lineage suggesting syndrome (family history/genogram)
  • Relative with early-onset diagnosis
  • Reproductive decision concerns (pre-natal/pre- implantation)
17
Q

What is the purpose of predictive testing for colorectal cancer?

A

Risk and surveillance assessment